Inovio Pharmaceuticals Inc (INO):企業の財務・戦略的SWOT分析

◆英語タイトル:Inovio Pharmaceuticals Inc (INO) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1666
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Inovio Pharmaceuticals Inc (INO) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Inovio Pharmaceuticals Inc (Inovio) is a biotechnology company that focuses on developing a portfolio of DNA immunotherapies and vaccines for the treatment and prevention of various cancers and infectious diseases. The company develops products based on its core SynCon DNA plasmid technology and electroporation delivery technology. The company’s product pipeline includes VGX-3100 for the treatment of cervical HSIL, vulvar HSIL, anal HSIL; INO-5401for glioblastoma; INO-3107 for recurrent respiratory papillomatosis (RRP); MEDI0457 for head and neck cancer and INO-5151 for the treatment of Prostate cancer. The company also has platform development programs in partnerships with several companies and government bodies focused at developing therapeutics for infectious diseases such as HIV, ebola, zika virus, middle east respiratory syndrome (MERS), lassa fever and COVID-19 disease. Inovio is headquartered in Plymouth Meeting, Pennsylvania, the US.

Inovio Pharmaceuticals Inc Key Recent Developments

Apr 02,2020 Australia’s CSIRO starts first stage of coronavirus vaccine testing
Mar 12,2020 INOVIO Pharmaceuticals reports 2019 fourth quarter and year-end financial results
Mar 04,2020 Inovio Pharmaceuticals set to trial Covid-19 vaccine in April
Jan 31,2020 Coronavirus: Australia’s CSIRO aims to enable vaccine development

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Inovio Pharmaceuticals Inc – Key Facts
Inovio Pharmaceuticals Inc – Key Employees
Inovio Pharmaceuticals Inc – Key Employee Biographies
Inovio Pharmaceuticals Inc – Major Products and Services
Inovio Pharmaceuticals Inc – History
Inovio Pharmaceuticals Inc – Company Statement
Inovio Pharmaceuticals Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Inovio Pharmaceuticals Inc – Business Description
Inovio Pharmaceuticals Inc – Corporate Strategy
Inovio Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Inovio Pharmaceuticals Inc – Strengths
Inovio Pharmaceuticals Inc – Weaknesses
Inovio Pharmaceuticals Inc – Opportunities
Inovio Pharmaceuticals Inc – Threats
Inovio Pharmaceuticals Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Inovio Pharmaceuticals Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 02, 2020: Australia’s CSIRO starts first stage of coronavirus vaccine testing
Mar 12, 2020: INOVIO Pharmaceuticals reports 2019 fourth quarter and year-end financial results
Mar 04, 2020: Inovio Pharmaceuticals set to trial Covid-19 vaccine in April
Jan 31, 2020: Coronavirus: Australia’s CSIRO aims to enable vaccine development
Jan 30, 2020: Inovio collaborating with Beijing Advaccine to advance INO-4800 vaccine against new coronavirus In China
Jan 29, 2020: VGXI to manufacture vaccine against Novel Coronavirus under CEPI funded collaboration
Jan 24, 2020: Coronavirus: Inovio and Moderna get CEPI funding to develop vaccine
Jan 15, 2020: Inovio welcomes biotech leader to its board of directors
Jan 07, 2020: BLS Pharma alleges Inovio’s breach of contract obstructed ability to deliver testosterone replacement therapy for hypogonadism and the transgender community
Jan 06, 2020: Inovio provides update on clinical program plans for 2020
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Inovio Pharmaceuticals Inc, Key Facts
Inovio Pharmaceuticals Inc, Key Employees
Inovio Pharmaceuticals Inc, Key Employee Biographies
Inovio Pharmaceuticals Inc, Major Products and Services
Inovio Pharmaceuticals Inc, History
Inovio Pharmaceuticals Inc, Other Locations
Inovio Pharmaceuticals Inc, Subsidiaries
Inovio Pharmaceuticals Inc, Key Competitors
Inovio Pharmaceuticals Inc, Ratios based on current share price
Inovio Pharmaceuticals Inc, Annual Ratios
Inovio Pharmaceuticals Inc, Annual Ratios (Cont...1)
Inovio Pharmaceuticals Inc, Interim Ratios
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Inovio Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Inovio Pharmaceuticals Inc, Performance Chart (2015 - 2019)
Inovio Pharmaceuticals Inc, Ratio Charts
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Inovio Pharmaceuticals Inc (INO):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CG Power and Industrial Solutions Ltd (CGPOWER):電力:M&Aディール及び事業提携情報
    Summary CG Power and Industrial Solutions Ltd (CG), formerly Crompton Greaves Limited, is a provider of various solutions for the management and application of electrical energy. It carries out the design, manufacture and marketing of electrical products and services related to utilities, power gene …
  • Probiodrug AG (PBD)-製薬・医療分野:企業M&A・提携分析
    Summary Probiodrug AG (Probiodrug) is a biopharmaceutical company that conducts research and development of therapies for Alzheimer’s disease. The company provides three pipeline drug candidates such as PQ912, PBD-C06 and PQ1565. Its PQ912 drug candidate is a small molecule glutaminyl cyclase (QC) i …
  • Eurazeo SA:企業のM&A・事業提携・投資動向
    Eurazeo SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Eurazeo SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Lea County Electric Cooperative Inc:企業の戦略的SWOT分析
    Lea County Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Deutsche Borse Ag:企業の戦略・SWOT・財務分析
    Deutsche Borse Ag - Strategy, SWOT and Corporate Finance Report Summary Deutsche Borse Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • International Seaways Inc (INSW):石油・ガス:M&Aディール及び事業提携情報
    Summary International Seaways Inc (INSW) owns and operates a fleet of oceangoing vessels involved in the transportation of crude oil and petroleum products. The company holds ownership in LNG (liquefied natural gas) carriers and FSO (floating storage and offloading) service vessels. It charters the …
  • Ibersol S.G.P.S., S.A.
    Ibersol S.G.P.S., S.A. - Strategy, SWOT and Corporate Finance Report Summary Ibersol S.G.P.S., S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Vyome Biosciences Pvt Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Vyome Biosciences Pvt Ltd (Vyome) is a research center that develops drugs for antibiotics-resistant acne and other opportunist pathogens. The center’s platforms modify active agents based on genomic information of the disease causing micro organism. Its pro-drug platform develops therapeuti …
  • Enel Green Power SpA:企業の戦略的SWOT分析
    Enel Green Power SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Sterling Bank Plc
    Sterling Bank Plc - Strategy, SWOT and Corporate Finance Report Summary Sterling Bank Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Pharmstandard:企業の戦略的SWOT分析
    Pharmstandard - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • TomTom NV (TOM2):企業の財務・戦略的SWOT分析
    TomTom NV (TOM2) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Insperity Inc (NSP)
    Insperity Inc (NSP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Unimedic AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Unimedic AB (Unimedic), formerly Ergobe Pharma AB, a subsidiary of MedCap AB, is a pharmaceutical company which develops, manufactures, distributes and markets pharmaceutical products. The company offers non-licensed, extemporaneous, and licensed pharmaceuticals targeting the therapy areas w …
  • CSS Industries, Inc. (CSS):企業の財務・戦略的SWOT分析
    CSS Industries, Inc. (CSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Bank of England:企業の戦略・SWOT・財務情報
    Bank of England - Strategy, SWOT and Corporate Finance Report Summary Bank of England - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Evotec AG (EVT):医療機器:M&Aディール及び事業提携情報
    Summary Evotec AG (Evotec) is a drug discovery alliance and development partnership company. It identifies and develops small molecule drugs across various therapeutic areas such as, cancer, neurological and nephrological conditions, cardiovascular, inflammation, pain, metabolic and respiratory dise …
  • Merafe Resources Ltd
    Merafe Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Merafe Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Fog Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Fog Pharmaceuticals Inc (Fog Pharmaceuticals) is a clinical-stage biotechnology company that discovers and develops next-generation peptide inhibitors that target traditionally undruggable intracellular protein-protein interactions. The company develops cell-penetrating miniproteins (CPMPs), …
  • Program for Appropriate Technology in Health:製薬・医療:M&Aディール及び事業提携情報
    Summary Program for Appropriate Technology in Health (PATH) is a non-profit organization that improves health in women and children. The organization offers vaccines, drugs, diagnostics, devices, system and service innovations, and digital health solutions. It develops diagnostics for HIV and other …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆